{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:25:53Z","timestamp":1793413553335,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1038\/s41401-025-01664-x","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T06:04:05Z","timestamp":1760681045000},"page":"689-700","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Inhibiting mPGES-2 impedes renal cyst growth in mice with polycystic kidney disease"],"prefix":"10.1038","volume":"47","author":[{"given":"Dan-dan","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan-lan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru-meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bu-hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-xue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-ying","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"1664_CR1","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0140-6736(18)32782-X","volume":"393","author":"E Cornec-Le Gall","year":"2019","unstructured":"Cornec-Le Gall E, Alam A, Perrone RD. Autosomal dominant polycystic kidney disease. Lancet. 2019;393:919\u201335.","journal-title":"Lancet"},{"key":"1664_CR2","first-page":"69","volume":"3","author":"CR Halvorson","year":"2010","unstructured":"Halvorson CR, Bremmer MS, Jacobs SC. Polycystic kidney disease: inheritance, pathophysiology, prognosis, and treatment. Int J Nephrol Renovasc Dis. 2010;3:69\u201383.","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"1664_CR3","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s41581-019-0155-2","volume":"15","author":"C Gimpel","year":"2019","unstructured":"Gimpel C, Bergmann C, Bockenhauer D, Breysem L, Cadnapaphornchai MA, Cetiner M, et al. International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people. Nat Rev Nephrol. 2019;15:713\u201326.","journal-title":"Nat Rev Nephrol"},{"key":"1664_CR4","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1172\/JCI72272","volume":"124","author":"PC Harris","year":"2014","unstructured":"Harris PC, Torres VE. Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease. J Clin Invest. 2014;124:2315\u201324.","journal-title":"J Clin Invest"},{"key":"1664_CR5","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nrneph.2017.127","volume":"13","author":"MB Lanktree","year":"2017","unstructured":"Lanktree MB, Chapman AB. New treatment paradigms for ADPKD: moving towards precision medicine. Nat Rev Nephrol. 2017;13:750\u201368.","journal-title":"Nat Rev Nephrol"},{"key":"1664_CR6","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41581-019-0143-6","volume":"15","author":"D Douguet","year":"2019","unstructured":"Douguet D, Patel A, Honor\u00e9 E. Structure and function of polycystins: insights into polycystic kidney disease. Nat Rev Nephrol. 2019;15:412\u201322.","journal-title":"Nat Rev Nephrol"},{"key":"1664_CR7","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1681\/ASN.2013080864","volume":"26","author":"WN Leonhard","year":"2015","unstructured":"Leonhard WN, Zandbergen M, Veraar K, van den Berg S, van der Weerd L, Breuning M, et al. Scattered deletion of PKD1 in kidneys causes a cystic snowball effect and recapitulates polycystic kidney disease. J Am Soc Nephrol. 2015;26:1322\u201333.","journal-title":"J Am Soc Nephrol"},{"key":"1664_CR8","doi-asserted-by":"publisher","first-page":"10166","DOI":"10.1074\/jbc.M112.418475","volume":"288","author":"F Takusagawa","year":"2013","unstructured":"Takusagawa F. Microsomal prostaglandin E synthase type 2 (mPGES2) is a glutathione-dependent heme protein, and dithiothreitol dissociates the bound heme to produce active prostaglandin E2 synthase in vitro. J Biol Chem. 2013;288:10166\u201375.","journal-title":"J Biol Chem"},{"key":"1664_CR9","doi-asserted-by":"publisher","first-page":"8414","DOI":"10.1021\/bi700605m","volume":"46","author":"T Yamada","year":"2007","unstructured":"Yamada T, Takusagawa F. PGH2 degradation pathway catalyzed by GSH-heme complex bound microsomal prostaglandin E2 synthase type 2: the first example of a dual-function enzyme. Biochemistry. 2007;46:8414\u201324.","journal-title":"Biochemistry"},{"key":"1664_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114075","volume":"43","author":"D Zhong","year":"2024","unstructured":"Zhong D, Chen J, Qiao R, Song C, Hao C, Zou Y, et al. Genetic or pharmacologic blockade of mPGES-2 attenuates renal lipotoxicity and diabetic kidney disease by targeting Rev-Erb\u03b1\/FABP5 signaling. Cell Rep. 2024;43:114075.","journal-title":"Cell Rep"},{"key":"1664_CR11","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/hep.32671","volume":"78","author":"D Zhong","year":"2023","unstructured":"Zhong D, Cai J, Hu C, Chen J, Zhang R, Fan C, et al. Inhibition of mPGES-2 ameliorates NASH by activating NR1D1 via heme. Hepatol (Balt, Md). 2023;78:547\u201361.","journal-title":"Hepatol (Balt, Md)"},{"key":"1664_CR12","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/j.jhep.2014.07.018","volume":"61","author":"Y Sun","year":"2014","unstructured":"Sun Y, Jia Z, Yang G, Kakizoe Y, Liu M, Yang KT, et al. mPGES-2 deletion remarkably enhances liver injury in streptozotocin-treated mice via induction of GLUT2. J Hepatol. 2014;61:1328\u201336.","journal-title":"J Hepatol"},{"key":"1664_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.prostaglandins.2008.10.003","volume":"88","author":"LA Jania","year":"2009","unstructured":"Jania LA, Chandrasekharan S, Backlund MG, Foley NA, Snouwaert J, Wang IM, et al. Microsomal prostaglandin E synthase-2 is not essential for in vivo prostaglandin E2 biosynthesis. Prostaglandins Other Lipid Mediat. 2009;88:73\u201381.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"1664_CR14","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1007\/s00204-019-02543-1","volume":"93","author":"H Wang","year":"2019","unstructured":"Wang H, Zhang R, Zhu Y, Teng T, Cheng Y, Chowdhury A, et al. Microsomal prostaglandin E synthase 2 deficiency is resistant to acetaminophen-induced liver injury. Arch Toxicol. 2019;93:2863\u201378.","journal-title":"Arch Toxicol"},{"key":"1664_CR15","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s42255-022-00536-6","volume":"4","author":"D Zhong","year":"2022","unstructured":"Zhong D, Wan Z, Cai J, Quan L, Zhang R, Teng T, et al. mPGES-2 blockade antagonizes \u03b2-cell senescence to ameliorate diabetes by acting on NR4A1. Nat Metab. 2022;4:269\u201383.","journal-title":"Nat Metab"},{"key":"1664_CR16","doi-asserted-by":"publisher","first-page":"F332","DOI":"10.1152\/ajprenal.00126.2018","volume":"315","author":"EE Dixon","year":"2018","unstructured":"Dixon EE, Woodward OM. Three-dimensional in vitro models answer the right questions in ADPKD cystogenesis. Am J Physiol Ren Physiol. 2018;315:F332\u2013f5.","journal-title":"Am J Physiol Ren Physiol"},{"key":"1664_CR17","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nrneph.2011.109","volume":"7","author":"JJ Grantham","year":"2011","unstructured":"Grantham JJ, Mulamalla S, Swenson-Fields KI. Why kidneys fail in autosomal dominant polycystic kidney disease. Nat Rev Nephrol. 2011;7:556\u201366.","journal-title":"Nat Rev Nephrol"},{"key":"1664_CR18","first-page":"1153","volume":"13","author":"J Lanoix","year":"1996","unstructured":"Lanoix J, D\u2019Agati V, Szabolcs M, Trudel M. Dysregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disease (ADPKD). Oncogene. 1996;13:1153\u201360.","journal-title":"Oncogene"},{"key":"1664_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44410-9","volume":"15","author":"MS Tham","year":"2024","unstructured":"Tham MS, Cottle DL, Zylberberg AK, Short KM, Jones LK, Chan P, et al. Deletion of Aurora kinase A prevents the development of polycystic kidney disease in mice. Nat Commun. 2024;15:371.","journal-title":"Nat Commun"},{"key":"1664_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1681\/ASN.0000000000000265","volume":"35","author":"I Weisser","year":"2024","unstructured":"Weisser I, Eckberg K, D\u2019Amico S, Buttram D, Aboudehen K. Ablation of long noncoding RNA Hoxb3os exacerbates cystogenesis in mouse polycystic kidney disease. J Am Soc Nephrol. 2024;35:41\u201355.","journal-title":"J Am Soc Nephrol"},{"key":"1664_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41581-023-00694-0","volume":"19","author":"AB Sanz","year":"2023","unstructured":"Sanz AB, Sanchez-Ni\u00f1o MD, Ramos AM, Ortiz A. Regulated cell death pathways in kidney disease. Nat Rev Nephrol. 2023;19:281\u201399.","journal-title":"Nat Rev Nephrol"},{"key":"1664_CR22","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/s41401-023-01192-6","volume":"45","author":"MY Wang","year":"2024","unstructured":"Wang MY, Yu TX, Wang QY, Han X, Hu X, Ye SJ, et al. OTUD1 promotes hypertensive kidney fibrosis and injury by deubiquitinating CDK9 in renal epithelial cells. Acta Pharmacol Sin. 2024;45:765\u201376.","journal-title":"Acta Pharmacol Sin"},{"key":"1664_CR23","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.kint.2023.12.006","volume":"105","author":"AK Zylberberg","year":"2024","unstructured":"Zylberberg AK, Cottle DL, Runting J, Rodrigues G, Tham MS, Jones LK, et al. Modulating inflammation with interleukin 37 treatment ameliorates murine autosomal dominant polycystic kidney disease. Kidney Int. 2024;105:731\u201343.","journal-title":"Kidney Int"},{"key":"1664_CR24","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.kint.2022.08.036","volume":"103","author":"N Dwivedi","year":"2023","unstructured":"Dwivedi N, Jamadar A, Mathew S, Fields TA, Rao R. Myofibroblast depletion reduces kidney cyst growth and fibrosis in autosomal dominant polycystic kidney disease. Kidney Int. 2023;103:144\u201355.","journal-title":"Kidney Int"},{"key":"1664_CR25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nrendo.2010.194","volume":"7","author":"T Furuyashiki","year":"2011","unstructured":"Furuyashiki T, Narumiya S. Stress responses: the contribution of prostaglandin E(2) and its receptors. Nat Rev Endocrinol. 2011;7:163\u201375.","journal-title":"Nat Rev Endocrinol"},{"key":"1664_CR26","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.cell.2009.01.015","volume":"136","author":"W Goessling","year":"2009","unstructured":"Goessling W, North TE, Loewer S, Lord AM, Lee S, Stoick-Cooper CL, et al. Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell. 2009;136:1136\u201347.","journal-title":"Cell"},{"key":"1664_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109674","volume":"36","author":"X He","year":"2021","unstructured":"He X, Smith SE, Chen S, Li H, Wu D, Meneses-Giles PI, et al. Tumor-initiating stem cell shapes its microenvironment into an immunosuppressive barrier and pro-tumorigenic niche. Cell Rep. 2021;36:109674.","journal-title":"Cell Rep"},{"key":"1664_CR28","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1124\/pr.112.007195","volume":"65","author":"U Yokoyama","year":"2013","unstructured":"Yokoyama U, Iwatsubo K, Umemura M, Fujita T, Ishikawa Y. The prostanoid EP4 receptor and its signaling pathway. Pharmacol Rev. 2013;65:1010\u201352.","journal-title":"Pharmacol Rev"},{"key":"1664_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.61","volume":"7","author":"S Parida","year":"2016","unstructured":"Parida S, Pal I, Parekh A, Thakur B, Bharti R, Das S, et al. GW627368X inhibits proliferation and induces apoptosis in cervical cancer by interfering with EP4\/EGFR interactive signaling. Cell Death Dis. 2016;7:e2154.","journal-title":"Cell Death Dis"},{"key":"1664_CR30","doi-asserted-by":"publisher","first-page":"9063","DOI":"10.1128\/MCB.25.20.9063-9072.2005","volume":"25","author":"S Hino","year":"2005","unstructured":"Hino S, Tanji C, Nakayama KI, Kikuchi A. Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase stabilizes beta-catenin through inhibition of its ubiquitination. Mol Cell Biol. 2005;25:9063\u201372.","journal-title":"Mol Cell Biol"},{"key":"1664_CR31","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s41418-021-00880-2","volume":"29","author":"S Hu","year":"2022","unstructured":"Hu S, Ren S, Cai Y, Liu J, Han Y, Zhao Y, et al. Glycoprotein PTGDS promotes tumorigenesis of diffuse large B-cell lymphoma by MYH9-mediated regulation of Wnt-\u03b2-catenin-STAT3 signaling. Cell Death Differ. 2022;29:642\u201356.","journal-title":"Cell Death Differ"},{"key":"1664_CR32","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/leu.2008.27","volume":"22","author":"JA McCubrey","year":"2008","unstructured":"McCubrey JA, Steelman LS, Abrams SL, Bertrand FE, Ludwig DE, B\u00e4secke J, et al. Targeting survival cascades induced by activation of Ras\/Raf\/MEK\/ERK, PI3K\/PTEN\/Akt\/mTOR and Jak\/STAT pathways for effective leukemia therapy. Leukemia. 2008;22:708\u201322.","journal-title":"Leukemia"},{"key":"1664_CR33","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13046-022-02241-4","volume":"41","author":"AC Fuentes-Fayos","year":"2022","unstructured":"Fuentes-Fayos AC, P\u00e9rez-G\u00f3mez JM, ME GG, Jim\u00e9nez-Vacas JM, Blanco-Acevedo C, S\u00e1nchez-S\u00e1nchez R, et al. SF3B1 inhibition disrupts malignancy and prolongs survival in glioblastoma patients through BCL2L1 splicing and mTOR\/\u00df-catenin pathways imbalances. J Exp Clin Cancer Res. 2022;41:39.","journal-title":"J Exp Clin Cancer Res"},{"key":"1664_CR34","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.canlet.2021.05.010","volume":"513","author":"T Yang","year":"2021","unstructured":"Yang T, Xu R, Huo J, Wang B, Du X, Dai B, et al. WWOX activation by toosendanin suppresses hepatocellular carcinoma metastasis through JAK2\/Stat3 and Wnt\/\u03b2-catenin signaling. Cancer Lett. 2021;513:50\u201362.","journal-title":"Cancer Lett"},{"key":"1664_CR35","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1016\/j.celrep.2016.01.074","volume":"14","author":"J Wu","year":"2016","unstructured":"Wu J, Keng VW, Patmore DM, Kendall JJ, Patel AV, Jousma E, et al. Insertional mutagenesis identifies a STAT3\/Arid1b\/\u03b2-catenin pathway driving neurofibroma initiation. Cell Rep. 2016;14:1979\u201390.","journal-title":"Cell Rep"},{"key":"1664_CR36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.canlet.2008.05.035","volume":"271","author":"S Yan","year":"2008","unstructured":"Yan S, Zhou C, Zhang W, Zhang G, Zhao X, Yang S, et al. beta-Catenin\/TCF pathway upregulates STAT3 expression in human esophageal squamous cell carcinoma. Cancer Lett. 2008;271:85\u201397.","journal-title":"Cancer Lett"},{"key":"1664_CR37","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3324\/haematol.2010.027086","volume":"96","author":"M Anand","year":"2011","unstructured":"Anand M, Lai R, Gelebart P. \u03b2-catenin is constitutively active and increases STAT3 expression\/activation in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Haematologica. 2011;96:253\u201361.","journal-title":"Haematologica"},{"key":"1664_CR38","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/liv.14747","volume":"41","author":"K Kawasaki","year":"2021","unstructured":"Kawasaki K, Kuboki S, Furukawa K, Takayashiki T, Takano S, Ohtsuka M. LGR5 induces \u03b2-catenin activation and augments tumour progression by activating STAT3 in human intrahepatic cholangiocarcinoma. Liver Int. 2021;41:865\u201381.","journal-title":"Liver Int"},{"key":"1664_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166987","volume":"1870","author":"SA Yasinoglu","year":"2024","unstructured":"Yasinoglu SA, Kuipers TB, Suidgeest E, van der Weerd L, Mei H, Baelde HJ, et al. Transcriptomic profiling of Polycystic Kidney Disease identifies paracrine factors in the early cyst microenvironment. Biochim Biophys Acta Mol Basis Dis. 2024;1870:166987.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"1664_CR40","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.2215\/CJN.0000000000000269","volume":"18","author":"F Geurts","year":"2023","unstructured":"Geurts F, Xue L, Kramers BJ, Zietse R, Gansevoort RT, Fenton RA, et al. Prostaglandin E2, osmoregulation, and disease progression in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2023;18:1426\u201334.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1664_CR41","doi-asserted-by":"publisher","first-page":"F1622","DOI":"10.1152\/ajprenal.00036.2007","volume":"293","author":"G Elberg","year":"2007","unstructured":"Elberg G, Elberg D, Lewis TV, Guruswamy S, Chen L, Logan CJ, et al. EP2 receptor mediates PGE2-induced cystogenesis of human renal epithelial cells. Am J Physiol Ren Physiol. 2007;293:F1622\u201332.","journal-title":"Am J Physiol Ren Physiol"},{"key":"1664_CR42","doi-asserted-by":"publisher","first-page":"F1425","DOI":"10.1152\/ajprenal.00010.2012","volume":"303","author":"Y Liu","year":"2012","unstructured":"Liu Y, Rajagopal M, Lee K, Battini L, Flores D, Gusella GL, et al. Prostaglandin E(2) mediates proliferation and chloride secretion in ADPKD cystic renal epithelia. Am J Physiol Ren Physiol. 2012;303:F1425\u201334.","journal-title":"Am J Physiol Ren Physiol"},{"key":"1664_CR43","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1124\/pr.110.003517","volume":"63","author":"DF Woodward","year":"2011","unstructured":"Woodward DF, Jones RL, Narumiya S. International union of basic and clinical pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress. Pharmacol Rev. 2011;63:471\u2013538.","journal-title":"Pharmacol Rev"},{"key":"1664_CR44","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.pharmthera.2013.03.006","volume":"138","author":"V Konya","year":"2013","unstructured":"Konya V, Marsche G, Schuligoi R, Heinemann A. E-type prostanoid receptor 4 (EP4) in disease and therapy. Pharmacol Ther. 2013;138:485\u2013502.","journal-title":"Pharmacol Ther"},{"key":"1664_CR45","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1146\/annurev.physiol.70.113006.100614","volume":"70","author":"CM Hao","year":"2008","unstructured":"Hao CM, Breyer MD. Physiological regulation of prostaglandins in the kidney. Annu Rev Physiol. 2008;70:357\u201377.","journal-title":"Annu Rev Physiol"},{"key":"1664_CR46","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.molmed.2012.02.002","volume":"18","author":"MD Salvado","year":"2012","unstructured":"Salvado MD, Alfranca A, Haeggstr\u00f6m JZ, Redondo JM. Prostanoids in tumor angiogenesis: therapeutic intervention beyond COX-2. Trends Mol Med. 2012;18:233\u201343.","journal-title":"Trends Mol Med"},{"key":"1664_CR47","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1161\/01.CIR.0000128046.54681.97","volume":"109","author":"CY Xiao","year":"2004","unstructured":"Xiao CY, Yuhki K, Hara A, Fujino T, Kuriyama S, Yamada T, et al. Prostaglandin E2 protects the heart from ischemia-reperfusion injury via its receptor subtype EP4. Circulation. 2004;109:2462\u20138.","journal-title":"Circulation"},{"key":"1664_CR48","doi-asserted-by":"publisher","first-page":"13648","DOI":"10.1073\/pnas.1300820110","volume":"110","author":"G Natura","year":"2013","unstructured":"Natura G, B\u00e4r KJ, Eitner A, Boettger MK, Richter F, Hensellek S, et al. Neuronal prostaglandin E2 receptor subtype EP3 mediates antinociception during inflammation. Proc Natl Acad Sci USA. 2013;110:13648\u201353.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1664_CR49","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nrm2748","volume":"10","author":"A Sorkin","year":"2009","unstructured":"Sorkin A, von Zastrow M. Endocytosis and signalling: intertwining molecular networks. Nat Rev Mol Cell Biol. 2009;10:609\u201322.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1664_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108313","volume":"241","author":"D Cebulla","year":"2023","unstructured":"Cebulla D, van Geffen C, Kolahian S. The role of PGE2 and EP receptors on lung\u2019s immune and structural cells; possibilities for future asthma therapy. Pharmacol Ther. 2023;241:108313.","journal-title":"Pharmacol Ther"},{"key":"1664_CR51","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1158\/1078-0432.CCR-21-0299","volume":"28","author":"S Peng","year":"2022","unstructured":"Peng S, Hu P, Xiao YT, Lu W, Guo D, Hu S, et al. Single-cell analysis reveals EP4 as a target for restoring T-cell infiltration and sensitizing prostate cancer to immunotherapy. Clin Cancer Res. 2022;28:552\u201367.","journal-title":"Clin Cancer Res"},{"key":"1664_CR52","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1126\/science.1116221","volume":"310","author":"MD Castellone","year":"2005","unstructured":"Castellone MD, Teramoto H, Williams BO, Druey KM, Gutkind JS. Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science. 2005;310:1504\u201310.","journal-title":"Science"},{"key":"1664_CR53","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1074\/jbc.M109440200","volume":"277","author":"H Fujino","year":"2002","unstructured":"Fujino H, West KA, Regan JW. Phosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2. J Biol Chem. 2002;277:2614\u20139.","journal-title":"J Biol Chem"},{"key":"1664_CR54","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-05-3460","volume":"66","author":"M Kawada","year":"2006","unstructured":"Kawada M, Seno H, Uenoyama Y, Sawabu T, Kanda N, Fukui H, et al. Signal transducers and activators of transcription 3 activation is involved in nuclear accumulation of beta-catenin in colorectal cancer. Cancer Res. 2006;66:2913\u20137.","journal-title":"Cancer Res"},{"key":"1664_CR55","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","volume":"7","author":"J Liu","year":"2022","unstructured":"Liu J, Xiao Q, Xiao J, Niu C, Li Y, Zhang X, et al. Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther. 2022;7:3.","journal-title":"Signal Transduct Target Ther"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01664-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01664-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01664-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T19:02:32Z","timestamp":1771959752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01664-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1664"],"URL":"https:\/\/doi.org\/10.1038\/s41401-025-01664-x","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}